Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1308, 2001-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Infliximab promising in paediatric Crohn's disease
Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. :
Infliximab: additional benefits in Crohn's disease
Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. :
Infliximab worth it for Crohn's disease in the UK
Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. :
Emerging drugs to treat Crohn's disease
By Strauch Ulrike Schölmerich Jürgen
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. :
Tamoxifen was used successfully to treat retroperitoneal fibrosis
Inpharma, Vol. 1, Iss. 1358, 2002-01 ,pp. :